| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 5 | |
| #2 | Canada | 5 | |
| #3 | China | 5 | |
| #4 | EPO (European Patent Office) | 5 | |
| #5 | Republic of Korea | 5 | |
| #6 | WIPO (World Intellectual Property Organization) | 5 | |
| #7 | Brazil | 4 | |
| #8 | United States | 4 | |
| #9 | Israel | 3 | |
| #10 | Mexico | 3 | |
| #11 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Sugars | |
| #4 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Zomer Eliezer | 35 |
| #2 | Shechter Sharon | 35 |
| #3 | Nir Raphael | 35 |
| #4 | George Ryan | 35 |
| #5 | Johnson Joseph M | 33 |
| #6 | Traber Peter G | 33 |
| #7 | Slate Deirdre | 13 |
| #8 | Eliezer Zomer | 7 |
| #9 | Raphael Nir | 7 |
| #10 | Peter G Traber | 7 |
| Publication | Filing date | Title |
|---|---|---|
| CA3069745A1 | Compounds for the prevention and treatment of medical disorders and uses thereof | |
| WO2018209276A1 | Compounds for the treatment of systemic insulin resistance disorders and the use thereof | |
| CA3080128A1 | Selenogalactoside compounds for the treatment of systemic insulin resistance disorders and the use thereof | |
| CN110869378A | Compounds for preventing and treating diseases and use thereof | |
| WO2017152048A1 | Selenogalactoside compounds for the prevention and treatment of diseases associated with galectin and the use thereof |